SITE010-0111

SITE010 (ESP) › SITE010-0111

SITE010-0111

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE010 (ESP) · Dr. Silva
consented 2026-01-17

enrolled

AEs

1

Serious

0

Dropout signal

–

Adverse events

1

Grade 1 Alopecia — outcome: RECOVERED/RESOLVED; onset 2023-02-23 (study day 220); relationship: not assessed

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.